From the Desk of the FDA Office of Combination Products – Strategic Priorities

2024 Combo Products Summit Agenda

session

From the Desk of the FDA Office of Combination Products – Strategic Priorities

October 9, 2024 @ 9:15 am

10:00 am

Moderator

Kim Belsky, Strategic Facilitator, Combination Products Summit, AFDO/RAPS Healthcare Products Collaborative

Speakers

James Bertram, Director of the Office of Combination Products (OCP), FDA
Danita Dixon, Associate Director for Information Management, Office of Clinical Policy and Programs, Office of the Commissioner, FDA

FDA’s Office of Combination Products serves as a liaison between industry and the necessary FDA Centers on the most pressing challenges faced by the Combination Products Industry. Learn firsthand what is being addressed by FDA now, and what is planned for the future on traditional and complex products.

This conference IS co-sponsored by the Food and Drug Administration (FDA) of the U.S. Department of Health and Human Services. The contents are those of the presenters and do not necessarily represent the official views of, nor an endorsement by, FDA/HHS or the U.S. government.

2024 Combo Products Summit Agenda

session